Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2015

01-10-2015 | Article

Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case–control study

Authors: O. Henig, G. Weber, M. B. Hoshen, M. Paul, L. German, A. Neuberger, I. Gluzman, A. Berlin, C. Shapira, R. D. Balicer

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2015

Login to get access

Abstract

The objective of this investigation was to identify risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) and its association with mortality. A population-based matched case–control study using the computerized database of Clalit Health Services (CHS) in the period between 2007 and 2012 was conducted. Hospitalized patients with CRAB colonization or infection were compared to hospitalized patients without evidence of A. baumannii, matched by age, ward of hospitalization, season, Charlson score, and length of hospitalization. Risk factors for CRAB isolation were searched for using multivariate analysis. Association of CRAB and other risk factors with mortality were assessed in the cohort. A total of 1190 patients with CRAB were matched to 1190 patients without CRAB. Low socioeconomic status was independently associated with CRAB isolation and CRAB bacteremia [odds ratio 2.18, 95 % confidence interval (CI) 1.02–5]. Other risk factors were invasive procedures and bacteremia with other pathogens prior to CRAB isolation, and various comorbidities. Among all patients, CRAB isolation was independently associated with increased mortality (hazard ratio 2.33, 95 % CI 2.08–2.6). Socioeconomic status is associated with health outcomes. Our population-based study revealed an almost doubled risk for CRAB in patients at lower socioeconomic status and an association with healthcare exposure. CRAB was associated with mortality and might become a risk indicator for complex morbidity and mortality.
Literature
1.
go back to reference Villegas MV, Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24(4):284–295CrossRefPubMed Villegas MV, Hartstein AI (2003) Acinetobacter outbreaks, 1977–2000. Infect Control Hosp Epidemiol 24(4):284–295CrossRefPubMed
2.
go back to reference Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5(12):939–951CrossRefPubMed Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5(12):939–951CrossRefPubMed
3.
go back to reference Ruiz J, Núñez ML, Pérez J, Simarro E, Martínez-Campos L, Gómez J (1999) Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis 18(4):292–295CrossRefPubMed Ruiz J, Núñez ML, Pérez J, Simarro E, Martínez-Campos L, Gómez J (1999) Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period. Eur J Clin Microbiol Infect Dis 18(4):292–295CrossRefPubMed
4.
go back to reference Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A et al (2014) Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 86(4):260–266CrossRefPubMed Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A et al (2014) Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect 86(4):260–266CrossRefPubMed
5.
go back to reference Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64(1):7–15CrossRefPubMed Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64(1):7–15CrossRefPubMed
6.
go back to reference Wadl M, Heckenbach K, Noll I, Ziesing S, Pfister W, Beer J et al (2010) Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002–2006. Infection 38(1):47–51CrossRefPubMed Wadl M, Heckenbach K, Noll I, Ziesing S, Pfister W, Beer J et al (2010) Increasing occurrence of multidrug-resistance in Acinetobacter baumannii isolates from four German University Hospitals, 2002–2006. Infection 38(1):47–51CrossRefPubMed
7.
go back to reference Abbo A, Carmeli Y, Navon-Venezia S, Siegman-Igra Y, Schwaber MJ (2007) Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 26(11):793–800CrossRefPubMed Abbo A, Carmeli Y, Navon-Venezia S, Siegman-Igra Y, Schwaber MJ (2007) Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 26(11):793–800CrossRefPubMed
8.
go back to reference Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J et al (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103CrossRefPubMedPubMedCentral Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J et al (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103CrossRefPubMedPubMedCentral
9.
go back to reference del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D et al (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11(7):540–546CrossRefPubMed del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle D et al (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11(7):540–546CrossRefPubMed
10.
go back to reference Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH et al (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case–control study. Antimicrob Agents Chemother 48(1):224–228CrossRefPubMedPubMedCentral Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH et al (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case–control study. Antimicrob Agents Chemother 48(1):224–228CrossRefPubMedPubMedCentral
11.
go back to reference Playford EG, Craig JC, Iredell JR (2007) Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 65(3):204–211CrossRefPubMed Playford EG, Craig JC, Iredell JR (2007) Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 65(3):204–211CrossRefPubMed
12.
go back to reference Corbella X, Montero A, Pujol M, Domínguez MA, Ayats J, Argerich MJ et al (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38(11):4086–4095PubMedPubMedCentral Corbella X, Montero A, Pujol M, Domínguez MA, Ayats J, Argerich MJ et al (2000) Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 38(11):4086–4095PubMedPubMedCentral
13.
go back to reference Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A et al (2008) Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother 62(5):1130–1137CrossRefPubMed Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A et al (2008) Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother 62(5):1130–1137CrossRefPubMed
14.
go back to reference Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V et al (2010) Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38(3):173–180CrossRefPubMed Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V et al (2010) Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38(3):173–180CrossRefPubMed
15.
go back to reference Levin AS, Mendes CM, Sinto SI, Sader HS, Scarpitta CR, Rodrigues E et al (1996) An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil. Infect Control Hosp Epidemiol 17(6):366–368CrossRefPubMed Levin AS, Mendes CM, Sinto SI, Sader HS, Scarpitta CR, Rodrigues E et al (1996) An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil. Infect Control Hosp Epidemiol 17(6):366–368CrossRefPubMed
16.
go back to reference Falagas ME, Bliziotis IA, Siempos II (2006) Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case–control studies. Crit Care 10(2):R48CrossRefPubMedPubMedCentral Falagas ME, Bliziotis IA, Siempos II (2006) Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case–control studies. Crit Care 10(2):R48CrossRefPubMedPubMedCentral
17.
go back to reference Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332CrossRefPubMed Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332CrossRefPubMed
18.
go back to reference Villar M, Cano ME, Gato E, Garnacho-Montero J, Miguel Cisneros J, Ruíz de Alegría C et al (2014) Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal. Medicine 93(5):202–210CrossRefPubMed Villar M, Cano ME, Gato E, Garnacho-Montero J, Miguel Cisneros J, Ruíz de Alegría C et al (2014) Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal. Medicine 93(5):202–210CrossRefPubMed
19.
go back to reference Bonelli RR, Moreira BM, Picão RC (2014) Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors. Drug Resist Updat 17(1–2):24–36CrossRefPubMed Bonelli RR, Moreira BM, Picão RC (2014) Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors. Drug Resist Updat 17(1–2):24–36CrossRefPubMed
20.
go back to reference Kristiansson C, Grape M, Gotuzzo E, Samalvides F, Chauca J, Larsson M et al (2009) Socioeconomic factors and antibiotic use in relation to antimicrobial resistance in the Amazonian area of Peru. Scand J Infect Dis 41(4):303–312CrossRefPubMed Kristiansson C, Grape M, Gotuzzo E, Samalvides F, Chauca J, Larsson M et al (2009) Socioeconomic factors and antibiotic use in relation to antimicrobial resistance in the Amazonian area of Peru. Scand J Infect Dis 41(4):303–312CrossRefPubMed
22.
go back to reference Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant 44(8):457–462CrossRefPubMed Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant 44(8):457–462CrossRefPubMed
23.
go back to reference Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J et al (2009) Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol 30(12):1186–1192CrossRefPubMed Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J et al (2009) Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol 30(12):1186–1192CrossRefPubMed
24.
go back to reference Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case–control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32(7):1055–1061CrossRefPubMed Harris AD, Karchmer TB, Carmeli Y, Samore MH (2001) Methodological principles of case–control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32(7):1055–1061CrossRefPubMed
25.
go back to reference Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y (2002) Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 34(12):1558–1563CrossRefPubMed Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y (2002) Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 34(12):1558–1563CrossRefPubMed
Metadata
Title
Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case–control study
Authors
O. Henig
G. Weber
M. B. Hoshen
M. Paul
L. German
A. Neuberger
I. Gluzman
A. Berlin
C. Shapira
R. D. Balicer
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2452-4

Other articles of this Issue 10/2015

European Journal of Clinical Microbiology & Infectious Diseases 10/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.